DCF — CGH MEDICAL CENTER
Enterprise Value: $-306.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-306.7M
Enterprise Value
$-99.1M
PV of Cash Flows
$-207.6M
PV of Terminal Value
$-334.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $254.5M | $-18.0M | -7.0% | $-28.7M | $-26.1M |
| Year 2 | $262.2M | $-15.9M | -6.0% | $-27.0M | $-22.3M |
| Year 3 | $270.0M | $-13.6M | -5.0% | $-25.1M | $-18.8M |
| Year 4 | $278.1M | $-12.7M | -5.0% | $-24.4M | $-16.7M |
| Year 5 | $286.5M | $-12.3M | -4.0% | $-24.5M | $-15.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-306.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$247.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07554579047159378
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5